The Cooper Companies (NASDAQ: COO) Q3 Earnings Preview: Key Financials and Analyst Expectations

• The Cooper Companies (NASDAQ: COO) is set to release its Q3 earnings, with analysts projecting $1.12 EPS and $1.10 billion revenue, indicating growth.
• Despite a recent stock decline to $67.69, an analyst raised the price target to $80.00, suggesting future potential.
• The company maintains a strong financial position with a debt-to-equity ratio of 0.30 and a current ratio of 1.27.

The Cooper Companies (NASDAQ: COO), a global medical device firm, is scheduled to release its third-quarter earnings report after the market closes on September 9, 2026. Investors are anticipating these crucial financial results, which will provide insight into the company's performance for the quarter that ended in July 2026.

Wall Street analysts are forecasting an earnings per share (EPS) of around $1.12. EPS shows how much profit the company makes for each share of its stock. As highlighted by Benzinga Pro, this projection is an increase from the $1.10 per share that The Cooper Companies reported in the same quarter last year.

Revenue expectations are set at approximately $1.10 billion, which would be an increase from the $1.06 billion generated in the same period a year ago. According to Zacks Equity Research, this represents a projected 3.60% year-over-year growth in sales, indicating a stable outlook from analysts for the company's top-line performance.

Despite these positive forecasts, The Cooper Companies' stock recently saw a 2.70% decline, closing at $67.69. Separately, Citigroup analyst Joanne Wuensch maintained a Neutral rating on the stock. However, the analyst also raised the price target from $76.00 to $80.00, suggesting a higher potential valuation in the future.

The company's financial position includes a debt-to-equity ratio of 0.30, which indicates it has low debt compared to its shareholder equity. Furthermore, its current ratio of 1.27 suggests it has enough assets to cover its short-term obligations. The company's valuation includes a price-to-sales ratio of 3.10.